Afimmune
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Pharmacokinetics, Pharmacodynamics and Safety of Epeleuton in Patients With Sickle Cell Disease Sickle Cell Disease | Phase 2 | 2024-01-10 |
| Terminated | Assess Efficacy and Safety of Epeleuton in Patients With Hypertriglyceridemia and Type 2 Diabetes Hypertriglyceridemia, Type 2 Diabetes | Phase 2 | 2020-10-13 |
| Terminated | Efficacy and Safety of Orally Administered DS102 in Patients With Acute Alcoholic Hepatitis Severe Acute Decompensated Alcoholic Hepatitis | Phase 2 | 2018-11-28 |
| Completed | Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease | Phase 2 | 2017-09-24 |
| Completed | Safety And Efficacy Study Of Orally Administered Epeleuton In Patients With NAFLD Non Alcoholic Fatty Liver Disease | Phase 2 | 2016-12-20 |